Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Janux Therapeutics Inc shares valued at $277,987 were purchased by Reardon Tighe on Nov 01 ’24. At $53.44 per share, Reardon Tighe acquired 5,202 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Lichter Jay purchased 1,139 shares, netting a total of over 60,723 in proceeds.
Before that, Avalon Ventures XI, L.P. had added 56,440 shares to its account. In a trade valued at $3,028,665, the 10% Owner bought Janux Therapeutics Inc shares for $53.66 each.
As published in their initiating research note from UBS on October 24, 2024, Janux Therapeutics Inc [JANX] has been a Buy and the price target has been revised to $69. Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in early September. As of May 30, 2024, Scotiabank has initiated its “Sector perform” rating for JANX. Earlier on March 21, 2024, BTIG Research initiated its rating. Their recommendation was “a Buy” for JANX stock.
Analyzing JANX Stock Performance
During the last five days, there has been a drop of approximately -1.89%. Over the course of the year, Janux Therapeutics Inc shares have jumped approximately 411.56%. Shares of the company reached a 52-week high of $65.60 on 05/03/24 and a 52-week low of $7.79 on 02/05/24. A 50-day SMA is recorded $48.64, while a 200-day SMA reached $41.40. Nevertheless, trading volume fell to 1.02 million shares from 0.45 million shares the previous day.
Support And Resistance Levels for Janux Therapeutics Inc (JANX)
According to the 24-hour chart, there is a support level at 53.70, which, if violated, would cause prices to drop to 52.51. In the upper region, resistance lies at 56.78. The next price resistance is at 58.67. RSI (Relative Strength Index) is 61.74 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.72, which suggests the price will increase in the coming days. Percent R is at 35.58%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
